Protalix BioTherapeutics (PLX) Operating Margin (QoQ) (2010 - 2026)
Protalix BioTherapeutics (PLX) Operating Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - |
| 10 | Protalix BioTherapeutics | 192.77 Mn | 152.11 Mn | 12.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,917.00 |
| Mar 31, 2026 | 11,372.00 |
| Dec 31, 2025 | -6,300.00 |
| Sep 30, 2025 | 445.00 |
| Jun 30, 2025 | 4,847.00 |
| Mar 31, 2025 | -8,056.00 |
| Dec 31, 2024 | 1,735.00 |
| Sep 30, 2024 | 4,024.00 |
| Jun 30, 2024 | 11,155.00 |
| Mar 31, 2024 | -7,601.00 |
| Dec 31, 2023 | -3,531.00 |
| Sep 30, 2023 | -7,646.00 |
| Jun 30, 2023 | 8,387.00 |
| Mar 31, 2023 | 331.00 |
| Dec 31, 2022 | -692.00 |
| Sep 30, 2022 | 4,108.00 |
| Jun 30, 2022 | -5,148.00 |
| Mar 31, 2022 | 5,512.00 |
| Dec 31, 2021 | -5,111.00 |
| Sep 30, 2021 | 12,698.00 |